Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features
Abstract
1. Introduction
2. Patients and Methods
Statistical Analysis
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Drago, F.; Broccolo, F.; Rebora, A. Pityriasis rosea: An update with a critical appraisal of its possible herpesviral etiology. J. Am. Acad. Dermatol. 2009, 61, 303–318. [Google Scholar] [CrossRef]
- Chuh, A.; Zawar, V.; Sciallis, G.F.; Kempf, W.; Lee, A. Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? Infect. Dis. Rep. 2016, 8, 6418. [Google Scholar] [CrossRef]
- Drago, F.; Ciccarese, G.; Merlo, G.; Trave, I.; Javor, S.; Rebora, A.; Parodi, A. Oral and cutaneous manifestations of viral and bacterial infections: Not only COVID-19 disease. Clin. Dermatol. 2021, 39, 384–404. [Google Scholar] [CrossRef]
- El-Shiemy, S.; Nassar, A.; Mokhtar, M.; Mabrouk, D. Light and electron microscopic studies of pityriasis rosea. Int. J. Dermatol. 1987, 26, 237–239. [Google Scholar] [CrossRef]
- Broccolo, F.; Drago, F.; Careddu, A.M.; Foglieni, C.; Turbino, L.; Cocuzza, C.E.; Gelmetti, C.; Lusso, P.; Rebora, A.E.; Malnati, M.S. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J. Invest. Dermatol. 2005, 124, 1234–1240. [Google Scholar] [CrossRef]
- Drago, F.; Malaguti, F.; Ranieri, E.; Losi, E.; Rebora, A. Human herpes virus-like particles in pityriasis rosea lesions: An electron microscopy study. J. Cutan. Pathol. 2002, 29, 359–361. [Google Scholar] [CrossRef]
- Drago, F.; Ciccarese, G.; Broccolo, F.; Ghio, M.; Contini, P.; Thanasi, H.; Parodi, A. The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea. Mediat. Inflamm. 2015, 2015, 438963. [Google Scholar] [CrossRef]
- Sanad, E.M.; Ibrahim, M.; Rachwan, M.; Shams, G.M. Serum Interleukin-36 in Pityriasis Rosea: A Potential Biomarker for Disease Severity. J. Clin. Aesthet. Dermatol. 2023, 16, 43–46. [Google Scholar] [PubMed]
- Gangemi, S.; Cannavò, S.P.; Guarneri, F.; Merendino, R.A.; Sturniolo, G.C.; Minciullo, P.L.; Di Pasquale, G.; Valenzise, M.; Drago, F.; Rebora, A. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. J. Eur. Acad. Dermatol. Venereol. 2006, 20, 1366–1367. [Google Scholar] [CrossRef] [PubMed]
- Drago, F.; Broccolo, F.; Ciccarese, G. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Clin. Dermatol. 2022, 40, 586–590. [Google Scholar] [CrossRef]
- De Biasi, S.; Meschiari, M.; Gibellini, L.; Bellinazzi, C.; Borella, R.; Fidanza, L.; Gozzi, L.; Iannone, A.; Lo Tartaro, D.; Mattioli, M.; et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 2020, 11, 3434. [Google Scholar] [CrossRef] [PubMed]
- Qin, C.; Zhou, L.; Hu, Z.; Zhang, S.; Yang, S.; Tao, Y.; Xie, C.; Ma, K.; Shang, K.; Wang, W.; et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020, 71, 762–768. [Google Scholar] [CrossRef] [PubMed]
- Christensen-Quick, A.; Lafferty, M.; Sun, L.; Marchionni, L.; DeVico, A.; Garzino-Demo, A. Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection. J. Virol. 2016, 90, 7833–7847. [Google Scholar] [CrossRef] [PubMed]
- Liang, X.-S.; Li, C.-Z.; Zhou, Y.; Wan, M.-B. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol. 2012, 12, 43. [Google Scholar]
- Evans, E.F.; Saraph, A.; Tokuyama, M. Transactivation of Human Endogenous Retroviruses by Viruses. Viruses 2024, 16, 1649. [Google Scholar] [CrossRef]
- El-Ela, M.A.; Shaarawy, E.; El-Komy, M.; Fawzy, M.; Hay, R.A.; Hegazy, R.; Sharobim, A.; Moustafa, N.; Rashed, L.; Sayed Amr, K.S. Is There a Link between Human Herpesvirus Infection and Toll-like Receptors in the Pathogenesis of Pityriasis Rosea? A Case-control Study. Acta Dermatovenerol. Croatica 2016, 24, 282–287. [Google Scholar]
- Yang, F.; Han, X.P. Expression of Toll-like receptor 3, 7 and 9 in peripheral blood lymphocytes from patients with Pityriasis rosea. Chin. J. Dermatol. 2012, 45, 1–5. [Google Scholar]
- Carty, M.; Bowie, A.G. Recent insights into the role of Toll-like receptors in viral infection. Clin. Exp. Immunol. 2010, 161, 397–406. [Google Scholar] [CrossRef]
- Drago, F.; Ciccarese, G.; Rebora, A.; Parodi, A. Pityriasis rosea and pityriasis rosea-like eruption: Can they be distinguished? J. Dermatol. 2014, 41, 864–865. [Google Scholar] [CrossRef] [PubMed]
- Ciccarese, G.; Broccolo, F.; Rebora, A.; Parodi, A.; Drago, F. Oropharyngeal lesions in pityriasis rosea. J. Am. Acad. Dermatol. 2017, 77, 833–837.e4. [Google Scholar] [CrossRef]
- Villalon-Gomez, J.M. Pityriasis Rosea: Diagnosis and Treatment. Am. Fam. Physician 2018, 97, 38–44. [Google Scholar]
- Errichetti, E. Dermoscopy in general dermatology (non-neoplastic dermatoses): Pitfalls and tips. Int. J. Dermatol. 2021, 60, 653–660. [Google Scholar] [CrossRef]
- Ciccarese, G.; Trave, I.; Herzum, A.; Parodi, A.; Drago, F. Dermatological manifestations of Epstein-Barr virus systemic infection: A case report and literature review. Int. J. Dermatol. 2020, 59, 1202–1209. [Google Scholar] [CrossRef]
- Drago, F.; Ciccarese, G.; Broccolo, F.; Javor, S.; Parodi, A. Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults. J. Med. Virol. 2015, 87, 1981–1984. [Google Scholar] [CrossRef]
- Ciccarese, G.; Facciorusso, A.; Herzum, A.; Fidanzi, C.; Recalcati, S.; Foti, C.; Drago, F. Comparative Efficacy of Different Pharmacological Treatments for Pityriasis Rosea: A Network Meta-Analysis. J. Clin. Med. 2024, 13, 6666. [Google Scholar] [CrossRef] [PubMed]
- Chuh, A.; Zawar, V.; Lee, A. Atypical presentations of pityriasis rosea: Case presentations. J. Eur. Acad. Dermatol. Venereol. 2005, 19, 120–126. [Google Scholar] [CrossRef] [PubMed]
- Leung, A.K.C.; Lam, J.M.; Leong, K.F.; Hon, K.L. Pityriasis Rosea: An Updated Review. Curr. Pediatr. Rev. 2021, 17, 201–211. [Google Scholar] [CrossRef]
- Urbina, F.; Das, A.; Sudy, E. Clinical variants of pityriasis rosea. World J. Clin. Cases 2017, 5, 203–211. [Google Scholar] [CrossRef]
- Potestio, L.; Martora, F.; Cacciapuoti, S.; Megna, M.; Villani, A.; Ruggiero, A. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review. Clin. Cosmet. Investig. Dermatol. 2024, 17, 51–57. [Google Scholar] [CrossRef]
- Drago, F.; Ciccarese, G.; Rebora, A.; Parodi, A. Relapsing pityriasis rosea. Dermatology 2014, 229, 316–318. [Google Scholar] [CrossRef] [PubMed]
- Gay, J.T.; Huq, M.E.; Saleh, H.M.; Gross, G.P. Herald Patch. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2024. [Google Scholar]
- Alsayyah, A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann. Diagn. Pathol. 2020, 47, 151546. [Google Scholar] [CrossRef] [PubMed]
- Ciccarese, G.; Facciorusso, A.; Mastrolonardo, M.; Herzum, A.; Parodi, A.; Drago, F. Atypical Manifestations of Syphilis: A 10-Year Retrospective Study. J. Clin. Med. 2024, 13, 1603. [Google Scholar] [CrossRef] [PubMed]
- Hsu, S.; Le, E.H.; Khoshevis, M.R. Differential diagnosis of annular lesions. Am. Fam. Physician 2001, 64, 289–296. [Google Scholar]
- Moriarty, B.; Hay, R.; Morris-Jones, R. The diagnosis and management of tinea. BMJ 2012, 345, e4380. [Google Scholar] [CrossRef]
- Maul, J.T.; Maier, P.W.; Anzengruber, F.; Murer, C.; Bosshard, P.P.; Kerl, K.; French, L.E.; Navarini, A.A. A case of tinea incognita and differential diagnosis of figurate erythema. Med. Mycol. Case Rep. 2017, 18, 8–11. [Google Scholar] [CrossRef]
- Müller, H.; Eisendle, K.; Bräuninger, W.; Kutzner, H.; Cerroni, L.; Zelger, B. Comparative analysis of immunohistochemistry, polymerase chain reaction and focus-floating microscopy for the detection of Treponema pallidum in mucocutaneous lesions of primary, secondary and tertiary syphilis. Br. J. Dermatol. 2011, 165, 50–60. [Google Scholar] [CrossRef]
- Towns, J.M.; Leslie, D.E.; Denham, I.; Wigan, R.; Azzato, F.; Williamson, D.A.; Lee, D.; Chow, E.P.F.; Fairley, C.K.; Graves, S.R.; et al. Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: A prospective, cross-sectional study. Lancet Infect. Dis. 2021, 21, 1324–1331. [Google Scholar] [CrossRef] [PubMed]
- Dunmire, S.K.; Hogquist, K.A.; Balfour, H.H. Infectious mononucleosis. Curr. Top. Microbiol. Immunol. 2015, 390, 211–240. [Google Scholar]
- Drago, F.; Ciccarese, G.; Rebora, A.; Broccolo, F.; Parodi, A. Pityriasis Rosea: A Comprehensive Classification. Dermatology 2016, 232, 431–437. [Google Scholar] [CrossRef]
Patient n° | Age | Sex | Herald Patch Site | Eruption Duration Days | Mucosal Lesions | Systemic Symptoms | Sampling Days (From the Onset of the Rash) | DNA Copies/mL Plasma HHV-6 | DNA Copies/mL Plasma HHV-7 | HHV-6 Antibody Titer IgG | HHV-6 Antibody Titer IgM | HHV-7 Antibody Titer IgG | HHV-7 Antibody Titer IgM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 26 | m | trunk | 32 | no | fatigue, headache, sore throat | 10 | 15 | <10 | 1/80 | 1/40 | 1/80 | NEG |
2 | 19 | f | trunk | 28 | no | fatigue, irritability | 6 | 23 | 12 | 1/320 | 1/80 | 1/80 | NEG |
3 | 31 | m | thigh | 25 | no | fatigue, lack of appetite | 12 | 10 | <10 | 1/80 | 1/80 | 1/40 | NEG |
4 | 18 | f | trunk | 20 | erythematous papules, petechiae | fatigue, sore throat, irritability, difficulty concentrating | 8 | 20 | 10 | 1/160 | 1/160 | 1/80 | 1/40 |
5 | 23 | f | trunk | 30 | no | fatigue, lack of appetite | 7 | 18 | NEG | 1/160 | 1/80 | 1/40 | NEG |
6 | 29 | f | trunk | 28 | petechiae, strawberry tongue | headache, irritability | 10 | 15 | 15 | 1/320 | 1/80 | 1/80 | 1/80 |
7 | 34 | m | trunk | 20 | no | no | 12 | 10 | NEG | 1/160 | 1/80 | 1/40 | NEG |
8 | 30 | m | trunk | 25 | no | fatigue, lack of appetite | 8 | 12 | NEG | 1/320 | 1/80 | 1/80 | 1/40 |
9 | 26 | m | trunk | 28 | no | sore throat | 10 | 18 | 15 | 1/160 | 1/80 | 1/160 | 1/80 |
10 | 20 | m | trunk | 25 | no | fatigue | 8 | 18 | 10 | 1/80 | 1/320 | 1/160 | 1/80 |
11 | 17 | f | trunk | 30 | erythematous papules, vesicles | fatigue, irritability, difficulty concentrating | 8 | 25 | 12 | 1/80 | 1/320 | 1/80 | 1/40 |
12 | 28 | m | trunk | 27 | no | headache, irritability | 7 | 30 | 10 | 1/160 | 1/160 | 1/40 | 1/40 |
13 | 31 | m | trunk | 25 | no | fatigue | 10 | 15 | <10 | 1/80 | 1/160 | 1/40 | NEG |
14 | 29 | f | trunk | 25 | no | no | 10 | 18 | <10 | 1/80 | 1/80 | 1/80 | 1/80 |
15 | 34 | m | trunk | 28 | no | sore throat | 8 | 12 | 15 | 1/160 | 1/40 | 1/80 | 1/40 |
16 | 30 | m | trunk | 30 | no | no | 10 | 25 | 10 | 1/80 | NEG | 1/80 | NEG |
17 | 24 | f | trunk | 24 | no | fatigue, insomnia | 10 | 15 | <10 | 1/160 | 1/160 | 1/160 | 1/40 |
18 | 35 | m | trunk | 30 | no | fatigue, lack of appetite | 7 | 20 | 12 | 1/80 | 1/40 | 1/80 | 1/40 |
19 | 31 | f | trunk | 24 | no | fatigue, irritability, difficulty concentrating | 10 | 15 | <10 | 1/80 | 1/80 | 1/80 | NEG |
Patient n° | Age | Sex | Herald Patch Site | Eruption Duration Days | Mucosal Lesions | Systemic Symptoms | Sampling Days (From the Onset of the Rash) | DNA Copies/mL Plasma HHV-6 | DNA Copies/mL Plasma HHV-7 | HHV-6 Antibody Titer IgG | HHV-6 Antibody Titer IgM | HHV-7 Antibody Titer IgG | HHV-7 Antibody Titer IgM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 18 | m | trunk | 38 | no | no | 8 | 35 | 15 | 1/80 | 1/320 | 1/40 | 1/160 |
2 | 28 | f | thigh | 35 | erythematous maculo-papules | fatigue, headache | 7 | 30 | 10 | 1/160 | 1/160 | 1/80 | 1/80 |
3 | 32 | m | trunk | 42 | macules, petechiae | fatigue, lack of appetite | 10 | 26 | <10 | 1/160 | 1/320 | 1/40 | 1/40 |
4 | 19 | f | trunk | 38 | no | fatigue, pruritus | 8 | 46 | 18 | 1/80 | 1/160 | 1/40 | NEG |
5 | 30 | m | trunk | 35 | no | no | 7 | 35 | 15 | 1/80 | 1/80 | 1/160 | 1/80 |
6 | 31 | m | thigh | 40 | no | fatigue, irritability, headache | 10 | 20 | <10 | 1/40 | 1/160 | 1/40 | NEG |
7 | 25 | f | trunk | 36 | no | fatigue, sore throat | 10 | 15 | 15 | 1/160 | 1/320 | 1/80 | 1/80 |
8 | 32 | m | trunk | 38 | erythematous macules and vescicles | fatigue, irritability, difficulty concentrating | 6 | 28 | 18 | 1/320 | 1/160 | 1/160 | 1/160 |
9 | 30 | f | thigh | 48 | erythematous papules and macules | fatigue, irritability, insomnia | 10 | 36 | 10 | 1/80 | 1/320 | 1/40 | 1/40 |
10 | 28 | m | trunk | 40 | no | headache, arthralgia, mialgia | 8 | 32 | 15 | 1/160 | 1/80 | 1/80 | NEG |
11 | 22 | f | trunk | 35 | erythematous macules and papules | fatigue, irritability | 10 | 56 | 20 | 1/80 | 1/160 | 1/40 | 1/80 |
12 | 33 | m | trunk | 32 | no | fatigue, sore throat | 6 | 42 | <10 | 1/80 | 1/320 | 1/40 | 1/40 |
13 | 21 | f | trunk | 40 | erythematous macules and papules | fatigue, irritability, difficulty concentrating | 8 | 35 | 15 | 1/40 | 1/80 | 1/40 | NEG |
14 | 21 | f | trunk | 38 | no | fatigue, lack of appetite | 10 | 46 | <10 | 1/80 | 1/80 | 1/80 | 1/40 |
15 | 32 | f | trunk | 35 | macules, papules, petechiae | fatigue, headache, irritability | 8 | 26 | 12 | 1/40 | 1/80 | 1/80 | 1/40 |
16 | 32 | m | trunk | 30 | no | fatigue | 10 | 20 | 15 | 1/80 | 1/80 | 1/40 | 1/40 |
17 | 28 | m | trunk | 35 | no | fatigue, pruritus, insomnia | 8 | 18 | 10 | 1/80 | 1/160 | 1/40 | NEG |
18 | 27 | m | thigh | 35 | erythematous macules, petechiae | fatigue, headache | 10 | 36 | 12 | 1/80 | 1/160 | 1/80 | 1/40 |
19 | 29 | m | thigh | 42 | no | fatigue, difficulty concentrating, irritability | 8 | 20 | 18 | 1/80 | 1/80 | 1/40 | 1/80 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Drago, F.; Herzum, A.; Varesano, S.; Serviddio, G.; Broccolo, F.; Ciccarese, G. Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features. Viruses 2025, 17, 119. https://doi.org/10.3390/v17010119
Drago F, Herzum A, Varesano S, Serviddio G, Broccolo F, Ciccarese G. Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features. Viruses. 2025; 17(1):119. https://doi.org/10.3390/v17010119
Chicago/Turabian StyleDrago, Francesco, Astrid Herzum, Serena Varesano, Gaetano Serviddio, Francesco Broccolo, and Giulia Ciccarese. 2025. "Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features" Viruses 17, no. 1: 119. https://doi.org/10.3390/v17010119
APA StyleDrago, F., Herzum, A., Varesano, S., Serviddio, G., Broccolo, F., & Ciccarese, G. (2025). Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features. Viruses, 17(1), 119. https://doi.org/10.3390/v17010119